Medcaw Investments PLC is a United Kingdom-based company incorporated in 2020 and listed on the London Stock Exchange under the ticker symbol MCI.L. The company focuses on identifying and acquiring mining projects in the precious metals sector, especially gold and other valuable commodities. Medcaw operates as a cash shell, using its access to capital markets and an experienced management team to pursue high-quality mining assets with the goal of creating long-term value for shareholders. In December 2022, Medcaw completed an initial public offering (IPO), raising £0.637 million by offering 6,370,820 ordinary shares at £0.10 each. The company announced plans to acquire a 90% stake in the Eagle Lake gold project in Ontario, Canada, which includes 95 mining claims over approximately 1,960 hectares within the Wabigoon Greenstone Belt. As of December 31, 2024, Medcaw reported a net loss of £432,360 with no revenue for the year, reflecting a decrease in losses compared to the prior year. The management team includes Sarah Cope, a Non-Executive Director with significant investment banking experience; Marcus Yeoman, a Non-Executive Chairman with a background in IT infrastructure and directorship; and Charlie Wood, an Executive Director with over 20 years of experience in financial and corporate roles in the natural resources sector. As of June 30, 2025, Medcaw's cash reserves stood at £8,668, and in September 2025, the company raised £550,000 through convertible loan notes to support its working capital and capital expenditure.
AI-researched from public web sources — may contain errors or omissions and is not a substitute for verifying independently.
MEDCAW INVESTMENTS PLC's offering is currently announced on AIM. MEDCAW INVESTMENTS PLC is headquartered in United Kingdom. It is classified under Materials.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with MEDCAW INVESTMENTS PLC.
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/medcaw-investments" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="MEDCAW INVESTMENTS PLC — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/medcaw-investments?theme=light as the src instead.
https://www.discoveripo.com/ipo/medcaw-investments/opengraph-image
MEDCAW INVESTMENTS PLC IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/medcaw-investments?utm_source=embed&utm_medium=text&utm_campaign=medcaw-investments
Get emailed when MEDCAW INVESTMENTS PLC's terms, price, or expected date change — no weekly noise, just this company.
MEDCAW INVESTMENTS PLC is listing on AIM.
Medcaw Investments PLC is a United Kingdom-based company incorporated in 2020 and listed on the London Stock Exchange under the ticker symbol MCI.L. The company focuses on identifying and acquiring mining projects in the precious metals sector, especially gold and other valuable commodities. Medcaw operates as a cash shell, using its access to capital markets and an experienced management team to pursue high-quality mining assets with the goal of creating long-term value for shareholders. In December 2022, Medcaw completed an initial public offering (IPO), raising £0.637 million by offering 6,370,820 ordinary shares at £0.10 each. The company announced plans to acquire a 90% stake in the Eagle Lake gold project in Ontario, Canada, which includes 95 mining claims over approximately 1,960 hectares within the Wabigoon Greenstone Belt. As of December 31, 2024, Medcaw reported a net loss of £432,360 with no revenue for the year, reflecting a decrease in losses compared to the prior year. The management team includes Sarah Cope, a Non-Executive Director with significant investment banking experience; Marcus Yeoman, a Non-Executive Chairman with a background in IT infrastructure and directorship; and Charlie Wood, an Executive Director with over 20 years of experience in financial and corporate roles in the natural resources sector. As of June 30, 2025, Medcaw's cash reserves stood at £8,668, and in September 2025, the company raised £550,000 through convertible loan notes to support its working capital and capital expenditure.
The UK Financial Conduct Authority's National Storage Mechanism — an intention-to-float or AIM pre-admission announcement date, not a confirmed first-dealings date. Retrieved Sep 17, 2026.
View the original filing on FCA NSM →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public securities-regulator filings, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy